The store will not work correctly when cookies are disabled.
3-Phenyl-5-(2,4-dimethoxyphenyl)-1H-pyrrolo[2,3-b]pyridine
ID: ALA3102940
PubChem CID: 72792755
Max Phase: Preclinical
Molecular Formula: C21H18N2O2
Molecular Weight: 330.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c(OC)c1
Standard InChI: InChI=1S/C21H18N2O2/c1-24-16-8-9-17(20(11-16)25-2)15-10-18-19(13-23-21(18)22-12-15)14-6-4-3-5-7-14/h3-13H,1-2H3,(H,22,23)
Standard InChI Key: BBRDOLSLQNRECU-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
11.3359 -13.9164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3347 -14.7437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0496 -15.1566 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.0478 -13.5036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6214 -13.5041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7631 -13.9128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7634 -14.7438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5538 -15.0005 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.0421 -14.3279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5534 -13.6559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9414 -12.9286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7666 -12.9036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1548 -12.1766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7185 -11.4753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8899 -11.5058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5053 -12.2333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6246 -12.6782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9109 -12.2659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1955 -12.6786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1983 -13.5079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9127 -13.9164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9157 -14.7414 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.2028 -15.1565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4804 -12.2672 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4791 -11.4422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 7 2 0
6 4 2 0
4 1 1 0
1 5 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
5 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 5 1 0
21 22 1 0
22 23 1 0
19 24 1 0
24 25 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 330.39 | Molecular Weight (Monoisotopic): 330.1368 | AlogP: 4.91 | #Rotatable Bonds: 4 |
Polar Surface Area: 47.14 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.85 | CX LogP: 4.20 | CX LogD: 4.20 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.58 | Np Likeness Score: -0.35 |
References
1. Gourdain S, Dairou J, Denhez C, Bui LC, Rodrigues-Lima F, Janel N, Delabar JM, Cariou K, Dodd RH.. (2013) Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity., 56 (23): [PMID:24188002] [10.1021/jm401049v] |